SVB Wealth’s Pacira BioSciences PCRX Stock Holding History

SVB Wealth’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,424	Closed	-$217K	–	916
2023 Q2	$217K	Sell	5,424 -26	-0.5%	-$1.07K	﹤0.01%	796
2023 Q1	$222K	Buy	5,450 +127	+2%	+$5.05K	﹤0.01%	844
2022 Q4	$206K	Sell	5,323 -5	-0.1%	-$243	﹤0.01%	903
2022 Q3	$283K	Buy	5,328 +324	+6%	+$18K	﹤0.01%	718
2022 Q2	$292K	Buy	5,004 +4	+0.1%	+$262	﹤0.01%	576
2022 Q1	$382K	Hold	5,000	–	–	0.01%	514
2021 Q4	$301K	Hold	5,000	–	–	﹤0.01%	578
2021 Q3	$280K	Hold	5,000	–	–	﹤0.01%	812
2021 Q2	$303K	Hold	5,000	–	–	﹤0.01%	751
2021 Q1	$350K	Hold	5,000	–	–	﹤0.01%	630
2020 Q4	$299K	Hold	5,000	–	–	﹤0.01%	623
2020 Q3	$301K	Hold	5,000	–	–	0.01%	522
2020 Q2	$262K	Buy	+5,000	New	+$209K	﹤0.01%	486
2020 Q1	–	Sell	-5,000	Closed	-$227K	–	664
2019 Q4	$227K	Buy	+5,000	New	+$212K	﹤0.01%	551
2019 Q3	–	Sell	-5,000	Closed	-$217K	–	523
2019 Q2	$217K	Buy	+5,000	New	+$212K	0.01%	490
2019 Q1	–	Sell	-5,000	Closed	-$215K	–	411
2018 Q4	$215K	Hold	5,000	–	–	0.01%	373
2018 Q3	$246K	Buy	+5,000	New	+$216K	0.01%	394
2018 Q2	–	Sell	-7,075	Closed	-$220K	–	457
2018 Q1	$220K	Buy	7,075 +350	+5%	+$12.5K	0.01%	414
2017 Q4	$307K	Buy	6,725 +75	+1%	+$2.97K	0.01%	389
2017 Q3	$250K	Hold	6,650	–	–	0.01%	414
2017 Q2	$317K	Buy	+6,650	New	+$309K	0.01%	400

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

SVB Wealth's PCRX Position: Q3 2023 in Review

SVB Wealth sold out of Pacira BioSciences (PCRX) in Q3 2023, closing a stake of 5,424 shares — an estimated $217K sold.

SVB Wealth first reported a position in PCRX in Q2 2017 and held it in 21 quarters. The position peaked at $382K in Q1 2022. 261 funds tracked by Wall St. Rank hold PCRX as of Q3 2023.

SVB Wealth reported no remaining Pacira BioSciences position as of Q3 2023 after selling out during the quarter.
SVB Wealth sold 5,424 Pacira BioSciences shares in Q3 2023, an estimated $217K.
SVB Wealth first reported a position in Pacira BioSciences in Q2 2017 and held it in 21 quarters.
SVB Wealth's Pacira BioSciences position peaked at $382K in Q1 2022.
261 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2023.

Based on SVB Wealth's 13F filing for Q3 2023, filed 23 Oct 2023.